Tripos Completes Sale of Discovery Informatics Business to Vector Capital Corporation

22-Mar-2007 - Tripos, Inc. announced that it completed the sale of the assets of its Discovery Informatics business to affiliates of Vector Capital. Vector Capital is a San Francisco-based private equity boutique specializing in buyouts, spinouts and recapitalizations of established technology ...

Tripos Completes Acquisition of Optive Research, a Molecular Discovery Software Company

06-Jan-2005 - Tripos, Inc. announced that it has acquired privately held Optive Research, Inc., a recognized leader in developing innovative software for computer-assisted molecular discovery, for $4.75 million in cash and 599,521 shares of Tripos stock. The cash portion of the deal was funded through a $4 ...

Sanofi-Synthelabo Recherche Selects Tripos for Drug Discovery Partnership

02-Dec-2004 - Tripos, Inc. announced that it has entered a strategic partnership with Sanofi-Synthelabo Recherche, an affiliate of Sanofi-Aventis. Sanofi-Synthelabo Recherche has identified a number of proprietary chemistry motifs that exhibit therapeutic potential in a wide range of target areas. Tripos will ...

Bayer HealthCare Selects Tripos to Provide Drug Discovery Software For Its Global Enterprise

27-May-2004 - Tripos, Inc. and Bayer HealthCare AG have announced an agreement to deploy Tripos' proprietary discovery informatics software, SYBYL(R) and UNITY(R), globally across Bayer's drug discovery and development organization. Under the terms of the agreement, Tripos will provide Bayer with license ...

Tripos Achieves Significant Milestone in Informatics Collaboration With Schering AG

12-Mar-2004 - Tripos, Inc. announced the completion of a significant milestone in its ongoing discovery informatics collaboration with Schering AG. Schering has accepted Tripos' AUSPYX(TM) data cartridge for Oracle as the foundation of its Enterprise Chemical Information Management System (ECIMS). ECIMS is ...

Tripos Amends Chemistry Collaboration with Pfizer

30-Jan-2004 - Tripos, Inc. announced an amendment to its strategic collaboration with Pfizer Inc. for the design, synthesis and purification of druglike compounds. Tripos will reduce file enrichment activities with Pfizer, but partially offsetting this reduction, Tripos will engage in new work for Pfizer in ...

Tripos and Chronogen Announce a Drug Discovery Partnership

Tripos to Provide Complete Drug Discovery Chemistry Services to Chronogen

14-Jan-2004 - Tripos, Inc. and Chronogen Inc. announced a three-year collaboration to discover and optimize small-molecule therapeutics for cardiovascular disorders. Under the agreement, Tripos will employ its knowledge-driven chemistry process to provide complete drug discovery chemistry services for ...

Critical Therapeutics Will Use Tripos' LeadHopping Technology To Identify New Target Compounds

23-Oct-2003 - Tripos, Inc. announced a collaboration with Critical Therapeutics, Inc. (CTI), a privately held biopharmaceutical company discovering and developing novel therapies for critical-care medicine. Under the agreement, Tripos will identify and optimize small-molecule agonists for CTI's development ...

Tripos Introduces Complete Laboratory Workflow and Knowledge Management Solutions

12-Aug-2003 - Tripos, Inc. (Nasdaq: TRPS), a leading provider of drug discovery informatics products and chemistry research, today announced the release of ChemCoreRIO(TM), ChemCoreREG(TM) and the Tripos Electronic Notebook(TM), the key components in its new informatics solution designed to streamline ...

Tripos to Build One of the Leading Informatics-Driven Drug Discovery Laboratories in Europe

- State-of-the-Art Chemical Synthesis Facilities to be Built in Cornwall, England -

29-Apr-2002 - ST. LOUIS, MO - April 25, 2002 - Responding to worldwide demand by pharmaceutical and biotechnology companies to accelerate timelines in the discovery of new drugs and therapeutics for the marketplace, the leading provider of drug discovery chemistry, software and enterprise informatics, Tripos, ...